6N3O | pdb_00006n3o

Identification of novel, potent and selective GCN2 inhibitors as first-in-class anti-tumor agents

Explore Sequence Annotations in 3D

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.